Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $17.5300 (-1.52%) ($17.5300 - $17.5300) on Wed. Dec. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.41% (three month average) | RSI | 48 | Latest Price | $17.5300(-1.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKK(47%) IBB(47%) ARKG(46%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.705% in a week (0% probabilities). VIXM(-41%) VXX(-29%) UNG(-16%) USO(-11%) TLT(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.705% (StdDev 3.41%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $12.99(-25.9%) | Resistance Level | $17.67 | 5 Day Moving Average | $17.49(0.23%) | 10 Day Moving Average | $17.61(-0.45%) | 20 Day Moving Average | $17.67(-0.79%) | To recent high | -11.9% | To recent low | 19.3% | Market Cap | $1.303b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |